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We hypothesized that disparities exist in the types of individuals
who have been studied and reported, relative to the actual 
cancer population. METHODS: Were searched MEDLINE,
EMBASE/Excerpta Medica, and Current Contents from January
1, 1998-July 2004 using the MeSH subheadings “prostatic-
neoplasms” and “quality of life” and the keywords, “prostate
cancer” and “quality of life.” Articles were selected if they met
the following inclusion criteria: English language literature, orig-
inal research, publication in a peer-reviewed journal. Articles
were excluded for the following reasons: fewer than 10 patients
studied; no HRQOL instrument used; editorial or review; devel-
opmental studies; unstructured or open-ended interviews used as
primary data collection. RESULTS: 293 articles met inclusion
and exclusion criteria. Studies originated from 23 countries; the
United States producing the majority (52%) followed by Canada
(8%) and the UK (7%). A total of 79,882 patients participated
in these studies (average: 274 patients per study). One hundred
eighty-three studies (68%) reported the mean age of the cohort;
but reporting of other demographic information was modest
overall. Among studies recording race, 82% of study participants
were white, 6% were black and less than 1% were Hispanic
white or Asian. Blacks were represented in very few studies with
2057 (41%) included in four studies. Eighty-six different types
of HRQOL instruments were recorded. The most common
included the European Organisation for Research and Treatment
of Cancer Quality of Life Questionnaire (26%), the SF-36
(25%), and the UCLA Prostate Cancer Index (20%). CON-
CLUSIONS: Many HRQOL studies of prostate cancer patients
have been published, but the data quality and reporting varies
widely. Racial minorities are underrepresented relative to their
proportions in most populations.
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OBJECTIVES: To develop a leukemia-speciﬁc subscale for the
Functional Assessment of Cancer Therapy (FACT) and assess the
linguistic validity of Afrikaans, Arabic, Czech, Korean, Por-
tuguese, Slovak and Spanish translations. METHODS: The
leukemia-speciﬁc subscale was developed through item genera-
tion from literature review and interviews with clinical experts
and patients in 9 countries. The FACT-Leukemia (FACT-Leu)
was then translated using the standard FACIT methodology: 2
forward translations, reconciling of the 2 forwards, back-trans-
lation to English, and 3 independent bilingual reviews. The
sample included 115 patients (57% male, mean age 46 years)
from 8 countries: South Africa, Egypt, Czech Republic, Brazil,
Korea, Slovak Republic, Spain, and US (Spanish). Patients diag-
nosed with leukemia completed the FACT-Leu in their native lan-
guage and then offered structured input on problems with
translation or content. Statistical and reliability analyses were
performed, and the participant comments were analyzed quali-
tatively. RESULTS: The Leu subscale had good reliability with
the combined sample (alpha = 0.88) and the Spanish sample
(alpha = 0.88). There were no negative patient comments related
to the FACT-Leu items in any language. In addition, all leukemia
subscale items had good item-total correlations in the combined
sample. Item-total correlations in the individual language
samples were reviewed to identify potential translation errors.
Four items were ﬂagged with this procedure: appetite, bleeding,
bruising, and worry about infections. These translations were
reviewed to ensure that the translation was not the cause of the
relatively low item-total correlation. One minor revision was
made to the Spanish and Afrikaans versions after testing. CON-
CLUSIONS: The FACT-Leu showed good reliability and lin-
guistic validity in the seven-language combined sample and in
the Spanish sample, and good linguistic validity across the indi-
vidual languages. These results contributed to a better under-
standing of how quality of life issues are perceived by leukemia
patients in different countries and supported cross-cultural com-
parability of instrument scores.
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WHAT ARE THE PSYCHOSOCIAL CONSEQUENCES OF AN
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OBJECTIVES: The EU recommends biennial breast cancer
screening for women 50–69 of age. If 1000 women are biennial
screened in ten years 20–30 women are diagnosed with breast
cancer. The reduction of the breast cancer mortality will shift for
one woman only; the other 19–29 women diagnosed with breast
cancer will die or survive regardless of the screening. In ﬁve
rounds of breast cancer screening more than 100 women will
experience to get a false-positive screening mammography.
Women recalled for further investigations after an abnormal
screening mammography, which after diagnosis is conﬁrmed to
be a false-positive result, experience signiﬁcant adverse psy-
chosocial consequences. METHODS: A prospective longitudinal
survey over one year from June 2004 included consecutively
women who participated in breast cancer screening. A validated
questionnaire, Consequences Of Screening on Breast Cancer
(COS-BC), speciﬁcally developed for measuring psychosocial
consequences of abnormal and false-positive screening mam-
mography was used as outcome measure. Previously Rasch
analyses have conﬁrmed that COS-BC encompasses four sub-
scales and three single items. The COS-BC was completed by
women with an abnormal screening mammography and women
with a normal screening mammography and the psychosocial
impact in these two groups was compared. RESULTS: All
together 453 women with an abnormal screening mammogra-
phy and 845 women with a normal screening mammography
completed the COS-BC. In all four dimensions and in the three
single items differences were found. Women with an abnormal
screening mammography had experienced more negative psy-
chosocial consequences compared to women with a normal
screening result. All differences were statistically signiﬁcant with
p-values were less than 0.001. CONCLUSION: It has severe psy-
chosocial consequences to have an abnormal screening mam-
mography, which ought to be taken into account when planning
breast cancer screening.
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OBJECTIVES: To evaluate the psychometric properties of the
Spanish version of the UCLA Prostate Cancer Index (UCLA-
PCI). METHODS: A longitudinal, multicenter study was per-
formed. Feasibility was tested by analyzing missing items, and
ceiling and ﬂoor effects were assessed. Internal consistency was
tested using Cronbach’s alpha. Patients were classiﬁed based on
Gleason grading: Group A: 2–6 (least aggressive tumor); Group
B: 7 (moderately aggressive); and Group C: 8–10 (most aggres-
